🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
This phase I clinical study is a phase I clinical study on the safety, tole...
Status
Unknown
Location
The first hospital of Jilin University
Start Date
2022-07-19
Trial ID
NCT05576584
Treatments Being Tested
This is a Phase 1b/2a multicenter, randomized, double-blind, placebo-contro...
Status
Completed
Location
Westmead Hospital
Start Date
2021-09-06
Trial ID
NCT05032196
The goal of this clinical trial is to learn the safety, tolerability and ph...
Status
Recruiting
Location
Nucleus Network Pty Ltd.
Start Date
2026-02-06
Trial ID
NCT07262281
Treatments Being Tested
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokine...
Status
Not Yet Recruiting
Location
No.49, Huayuan North Road, Haidian District, Beijing City
Start Date
2025-03-07
Trial ID
NCT06867406
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, single and multiple...
Status
Completed
Location
Pharmaron CPC InC
Start Date
2019-09-23
Trial ID
NCT04480697
Treatments Being Tested
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Adm...
Status
Completed
Location
Labcorp Cru
Start Date
2022-08-08
Trial ID
NCT05349097
Treatments Being Tested
A Phase I, single-center, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT02819687
F230 is a new Class 1 chemical drug jointly developed by Beijing Contini Ph...
Status
Recruiting
Location
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-05-15
Trial ID
NCT06899815
Treatments Being Tested
Randomized single ascending dose placebo controlled treatment of ACH-000029...
Status
Terminated
Location
Nucleus Network Pty Ltd
Start Date
2022-05-06
Trial ID
NCT05363839
Treatments Being Tested